oncology

OCTAVE trial will study COVID-19 vaccine response in immune-compromised population

A new study has launched in the UK aimed at assessing COVID-19 vaccine responses in individuals with compromised immune systems. “Patients with significant underlying diseases were generally excluded from COVID-19 vaccine studies to date – it is now important to confirm that the COVID-19 vaccines work well in such conditions,” said Prof Pam Kearns, of ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic